26-A-18846-ACC REAL WORLD OUTCOMES OF FINERENONE VS SPIRONOLACTONE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION(HFPEF) AND CHRONIC KIDNEY DISEASE (CKD): A PROPENSITY MATCHED ANALYSIS

View at publisher Summarise with VIRAT
Authors: Efeturi Maxwell Okorigba, Abdulraheem Eniola Hassan, Fatima Asad, Yussif Issaka, Huzaifah Qureshi, Abdul-Rahaman Adedolapo Ottun, Avilash Mondal, Aisha Jamal, Emmanuel Otabor, Amro Taha, Mohamed Alhajji, Lakshmi Muthukumar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Heart Failure Treatment and Management Chronic Kidney Disease and Diabetes Hormonal Regulation and Hypertension

Publication details

Journal / source
Journal of the American College of Cardiology
Volume
87
Issue
13
Pages
A742–A743
Publication date
27 March 2026
Language
EN